Anti-Retinoic Acid Receptor beta antibody [EPR2017]
- RabMAb
- Recombinant
- What is this?
0
(2 Reviews)
|
(7 Publications)
Rabbit Recombinant Monoclonal Retinoic Acid Receptor beta antibody. Suitable for IHC-P, ICC/IF, WB and reacts with Human samples. Cited in 7 publications.
View Alternative Names
HAP, NR1B2, RARB, Retinoic acid receptor beta, RAR-beta, HBV-activated protein, Nuclear receptor subfamily 1 group B member 2, RAR-epsilon
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Retinoic Acid Receptor beta antibody [EPR2017] (AB124701)
ab124701 at 1/100 dilution staining Retinoic Acid Receptor beta in paraffin-embedded Human kidney tissue by Immunohistochemistry.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- WB
Lab
Western blot - Anti-Retinoic Acid Receptor beta antibody [EPR2017] (AB124701)
All lanes:
Western blot - Anti-Retinoic Acid Receptor beta antibody [EPR2017] (ab124701) at 1/2000 dilution
Lane 1:
Daudi (Human Burkitt's lymphoma lymphoblast) whole cell lysates at 15 µg
Lane 2:
U-87 MG (Human glioblastoma-astrocytoma epithelial cell) whole cell lysates at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 50 kDa
Observed band size: 55 kDa
false
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Retinoic Acid Receptor beta antibody [EPR2017] (AB124701)
Immunocytochemistry/ Immunofluorescence analysis of HCT 116 (Human colorectal carcinoma epithelial cell) cells labeling Retinoic Acid Receptor beta with Purified ab124701 at 1 : 100 dilution (10 µg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 µg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1 : 1000 (2 µg/ml) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Retinoic Acid Receptor beta antibody [EPR2017] (AB124701)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human bladder carcinoma tissue sections labeling Retinoic Acid Receptor beta with Purified ab124701 at 1 : 100 dilution (10.3 µg/ml). Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0). Purified)ImmunoHistoProbe one step HRP Polymer (ready to use) was used for detection. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- WB
Unknown
Western blot - Anti-Retinoic Acid Receptor beta antibody [EPR2017] (AB124701)
All lanes:
Western blot - Anti-Retinoic Acid Receptor beta antibody [EPR2017] (ab124701) at 1/1000 dilution
Lane 1:
MCF7 cell lysates at 10 µg
Lane 2:
MDA-MB-435 cell lysates at 10 µg
Lane 3:
Daudi cell lysates at 10 µg
Lane 4:
U-87 MG cell lysates at 10 µg
Secondary
Lane 1:
Goat anti-Rabbit HRP at 1/20000 dilution
Lanes 2 - 4:
Goat anti-Rabbit HRP at 1/2000 dilution
Predicted band size: 50 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-Retinoic Acid Receptor beta antibody [EPR2017] (AB124701)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (2)
-
HRP Anti-Retinoic Acid Receptor beta antibody [EPR2017]
-
Anti-Retinoic Acid Receptor beta antibody [EPR2017] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Retinoic Acid Receptor beta plays a significant role in cell differentiation and development. It often forms heterodimers with retinoid X receptors (RXRs) to execute its functions. This interaction enhances the receptor's ability to modulate gene expression. The complex orchestrates a broad range of developmental processes particularly in embryogenesis and organogenesis. RARβ influences several cellular activities including the regulation of apoptosis and the maintenance of cellular homeostasis.
Pathways
The activity of Retinoic Acid Receptor beta integrates predominantly into the retinoic acid signaling pathway and the Wnt signaling pathway. Through these pathways RARβ contributes to the regulation of cell fate and the inhibition of cell proliferation. It functions alongside proteins such as RXRs in the retinoic acid pathway and may interact with components of the Wnt pathway like β-catenin to control gene transcription and cellular responses. These interactions guide various developmental and physiological processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9:e2203173 PubMed36031407
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 13: PubMed34439217
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 11:644592 PubMed34178631
2021
Applications
Unspecified application
Species
Unspecified reactive species
European journal of pharmacology 906:174199 PubMed34058203
2021
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 129:5381-5399 PubMed31487270
2019
Applications
Unspecified application
Species
Unspecified reactive species
Disease markers 2019:7138754 PubMed30944670
2019
Applications
Unspecified application
Species
Unspecified reactive species
BMC genomics 14:224 PubMed23557329
2013
Applications
WB
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com